NCT04263480 2025-04-04
CZAR-1
University of Ulm
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT03891355 2022-09-15
FIL_KLIMT
Fondazione Italiana Linfomi - ETS
Phase 2 Unknown
NCT01813227 2022-04-13
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
Hackensack Meridian Health
Phase 2 Completed
NCT03269552 2020-01-18
Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma
University of Washington
Phase 2 Terminated
NCT02042950 2019-05-01
A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01470196 2018-11-20
CaRD
Dana-Farber Cancer Institute
Phase 2 Completed